UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
Commission File Number 0-31653
NOTIFICATION OF LATE FILING
(Check One): [_] Form 10-K and Form 10-KSB [_] Form 11-K [_] Form 20-F
[X] Form 10-Q and Form 10-QSB [_] Form N-SAR
For Period Ended: April 30, 2004
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period ended: _________________
NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY
THAT THE COMMISSION HAS VERIFIED ANY
INFORMATION CONTAINED HEREIN.
If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification relates:
PART I - REGISTRANT INFORMATION
Enhance Biotech, Inc.
- --------------------------------------------------------------------------------
Full Name of Registrant
Becor Communications, Inc. (changed on March 23, 2003)
- --------------------------------------------------------------------------------
Former Name if Applicable
712 Fifth Avenue
- --------------------------------------------------------------------------------
Address of Principal Executive Office (Street & Number)
New York, New York 10019
- --------------------------------------------------------------------------------
City, State and Zip Code
12b25-1
PART II
RULE 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate.)
| (a) The reasons described in reasonable detail in Part III of this
| form could not be eliminated without unreasonable effort or
| expense;
|
| (b) The subject annual report, semi-annual report, transition report
| on Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will
[X] | be filed on or before the 15th calendar day following the
| prescribed due date; or the subject quarterly report or
| transition report on Form 10-Q, or portion thereof will be filed
| on or before the fifth calendar day following the prescribed due
| date; and
|
| (c) The accountant's statement or other exhibit required by Rule
| 12b-25(c) has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
N-SAR, N-CSR, or the transition report or portion thereof, could not be filed
within the prescribed time period:
Registrant recently changed auditors and is in the process of completing its
audited financials for the fiscal year ended January 31, 2004. Due to the
demands on Registrant's resources, Registrant has been delayed in compiling
information and documentation necessary for Registrant's independent
accountants' financial review and preparation of financial statements.
Registrant is working as expeditiously as possible to compile such information
and documentation and to deliver it to Registrant's independent accountants for
review, completion and filing within the required time frame.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification:
Christopher Every (212) 561-1716
- -------------------------------------------------------------------------------
(Name) (Area Code) (Telephone number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months or for such
shorter period that the registrant was required to file such report(s) been
filed? If the answer is no, identify report(s). [X] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
[ ] Yes [X] No
If so: attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
12b25-2
ENHANCE BIOTECH, INC.
- --------------------------------------------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: June 14, 2004 By: /s/ Christopher Every
------------------------------------------
Christopher Every, Chief Executive Officer
12b25-3